Table 2. Participant characteristics.
| Drug abusers | Controls | All | |
|---|---|---|---|
| Age (year) | 33.79 ± 7.60 | 34.46 ± 8.16 | 34.16 ± 7.92 |
| Sex | |||
| Male | 199 | 210 | 409 |
| Female | 216 | 289 | 505 |
| Unknown | 0 | 9 | 9 |
| BMI (kg/m2) | 22.03 ± 2.31 | 22.27 ± 3.79 | 22.14 ± 3.03 |
| GPT (U/L) | 56.78 ± 88.31 | 31.34 ± 72.15 | 42.41 ± 80.50 |
| GOT (U/L) | 37.79 ± 42.90 | 22.53 ± 11.61 | 29.17 ± 30.53 |
| GGT (U/L) | 29.25 ± 29.63 | 25.42 ± 24.96 | 26.57 ± 26.49 |
| Triglyceride (mmol/L) | 1.15 ± 0.66 | 1.31 ± 1.01 | 1.26 ± 0.92 |
| Cholesterol (mmol/L) | 4.49 ± 0.90 | 4.64 ± 0.93 | 4.59 ± 0.92 |
| HDLC (mmol/L) | 1.31 ± 0.27 | 1.22 ± 0.29 | 1.25 ± 0.29 |
| LDLC (mmol/L) | 2.96 ± 0.76 | 3.18 ± 0.93 | 3.11 ± 0.89 |
| BUN (mmol/L) | 3.53 ± 0.82 | 4.58 ± 1.08 | 4.26 ± 1.12 |
| CREA (μmol/L) | 58.00 ± 11.10 | 68.00 ± 15.36 | 64.90 ± 14.91 |
| Uric acid (μmol/L) | 304.8 ± 86.8 | 357.1 ± 91.6 | 341.0 ± 93.3 |
| GLU (mmol/L) | 4.49 ± 0.49 | 5.11 ± 0.98 | 4.92 ± 0.90 |
The values are presented as the mean ± SD where applicable. BMI, body mass index; GPT, glutamic-pyruvic transaminase; GOT, glutamic-oxaloacetic transaminase; GGT, gamma-glutamyl transferase; HDLC, high-density lipoprotein cholesterol; LDLC, low-density lipoprotein cholesterol; BUN, blood urea nitrogen; CREA, creatinine; GLU, glucose.